Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport
Journal of Cell Science · 2025
DOI: 10.1242/jcs.263889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Emma Lorentzon und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Molecular Biology, University of Gothenburg, Box 462, S-405 30 Göteborg, Sweden. Hauptthemen laut MEDLINE: Active Transport, Cell Nucleus, Arsenic, Saccharomyces cerevisiae, Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Gothenburg, Sven och Dagmar Saléns Stiftelse, Stiftelsen Bengt Lundqvists Minne.
Abstract (Originalsprache)
Human exposure to arsenicals is associated with devastating diseases such as cancer and neurodegeneration. At the same time, arsenic-based drugs are used as therapeutic agents. The ability of arsenic to directly bind to proteins is correlated with its toxic and therapeutic effects, highlighting the importance of elucidating arsenic–protein interactions. In this study, we took a proteomic approach and identified 174 proteins that bind to arsenic in Saccharomyces cerevisiae. Proteins involved in nucleocytoplasmic transport were markedly enriched among the arsenic-binding proteins, and we demonstrate that arsenic binding to nuclear import factors results in their relocation from the nuclear envelope and subsequent aggregation in the cytosol. Similarly, nuclear pore proteins that make up the nuclear pore complex mislocalized and aggregated in arsenic-exposed cells. Consequently, arsenic was shown to inhibit nuclear protein import and export. We propose a model in which arsenic binding to nuclear transport factors leads to their mislocalization and aggregation, which disrupts nucleocytoplasmic transport and causes arsenic sensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Molecular Biology, University of Gothenburg, Box 462, S-405 30 Göteborg, Sweden.
- Department of Molecular and Cell Biology, Boston University Henry M. Goldman School of Dental Medicine, Boston, MA 02118, USA.
ORCID-Profile: Johanna L Höög, David E Levin, Markus J Tamás
Förderung
- University of Gothenburg
- Sven och Dagmar Saléns Stiftelse
- Stiftelsen Bengt Lundqvists Minne
- Olle Engkvists Stiftelse
- Vetenskapsrådet
- NIGMS NIH HHS
- NIH HHS
- Cancerfonden
Zitieren
APA
Lorentzon, E., Lee, J., Masaryk, J., Keuenhof, K., Karlsson, N., Galipaud, C., Madsen, R., Höög, J. L., Levin, D. E., & Tamás, M. J. (2025). Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport. Journal of Cell Science. https://doi.org/10.1242/jcs.263889
Vancouver
Lorentzon E, Lee J, Masaryk J, Keuenhof K, Karlsson N, Galipaud C, et al. Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport. Journal of Cell Science. 2025. doi:10.1242/jcs.263889
BibTeX
@article{Lorentzon2025,
author = {Lorentzon, Emma and Lee, Jongmin and Masaryk, Jakub and Keuenhof, Katharina and Karlsson, Nora and Galipaud, Charlotte and Madsen, Rebecca and Höög, Johanna L and Levin, David E and Tamás, Markus J},
title = {Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport},
journal = {Journal of Cell Science},
year = {2025},
doi = {10.1242/jcs.263889}
}
EUVIMED